Comparative Early and Late Outcomes After Primary Percutaneous Coronary Intervention in ST-Segment Elevation and Non-ST-Segment Elevation Acute Myocardial Infarction (from the CADILLAC Trial)

American Journal of Cardiology

Volumn 98, Issue 3, 2006, Pages 331-337

  Cox, David A ^a   Stone, Gregg W ^d   Grines, Cindy L ^e   Stuckey, Thomas ^b   Zimetbaum, Peter J ^f   Tcheng, James E ^c   Turco, Mark ^g   Garcia, Eulogio ^h   Guagliumi, Giulio ⁱ   Iwaoka, Robert S ^a   Mehran, Roxana ^d   O'Neill, William W ^e   Lansky, Alexandra J ^d   Griffin, John J ^j  

^a Mid Carolina Cardiology   (United States)

^b MOSES H CONE MEMORIAL HOSPITAL   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d NewYork Presbyterian Hospital   (United States)

^e WILLIAM BEAUMONT HOSPITAL   (United States)

^f BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^g Doylestown Hospital   (United States)

^h HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

ⁱ OSPEDALI RIUNITI   (Italy)

^j Sentara Virginia Beach General Hospital   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; CLINICAL FEATURE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; FEMALE; HEART EJECTION FRACTION; HEART INFARCTION; HUMAN; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REPERFUSION; REVASCULARIZATION; ST SEGMENT ELEVATION; THORAX PAIN;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; ANTICOAGULANTS; BLOOD VESSEL PROSTHESIS IMPLANTATION; COATED MATERIALS, BIOCOMPATIBLE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; STENTS; STROKE VOLUME; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 33745941990     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.01.102     Document Type: Article

References (27)

1. Nunn C.M., O'Neill W.W., Rothbaum D., Stone G.W., O'Keefe J., Overlie P., Donohue B., Grines L., Browne K.F., Vlietstra R.E., et al. Long-term outcome after primary angioplasty. report from the Primary Angioplasty in Myocardial Infarction (PAMI-I) trial. J Am Coll Cardiol 33 (1999) 640-646
2. Keeley E.C., Boura J.A., and Grines C.K. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction. a quantitative review of 23 randomised trials. Lancet 361 (2003) 13-20
3. Zijlstra F., Hoorntje J.C., de Boer M.J., Reiffers S., Miedema K., Ottervanger J.P., van't Hof A.W., and Suryapranata H. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 341 (1999) 1413-1419
4. Andersen H.R., Nielsen T.T., Vesterlund T., Grande P., Abildgaard U., Thayssen P., Pedersen F., Mortensen L.S., and DANAMI-2 Investigators. Danish multicenter randomized study on fibrinolytic therapy versus acute coronary angioplasty in acute myocardial infarction. rationale and design of the DANish Trial in Acute Myocardial Infarction-2 (DANAMI-2). Am Heart J 146; (2003) 234-241
5. The Fibrinolytic Therapy Trialists (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction. collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients. Lancet 343 (1994) 311-322
6. Rogers W.J., Canto J.G., Lambrew C.T., Tiefenbrunn A.J., Kinkaid B., Shoultz D.A., Frederick P.D., and Every N. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the U.S. from 1990 through 1999. the National Registry of Myocardial Infarction 1, 2, and 3. J Am Coll Cardiol 36 (2000) 2056-2063
7. Zimetbaum P.J., and Josephson M.E. Use of the electrocardiogram in acute myocardial infarction. N Engl J Med 348; (2003) 933-940
8. Welch R.D., Zalenski R.J., Frederick P.D., Malmgren J.A., Compton S., Grzybowski M., Thomas S., Kowalenko T., Every N.R., and National Registry of Myocardial Infarction 2 and 3 Investigators. Prognostic value of a normal or nonspecific initial electrocardiogram in acute myocardial infarction. JAMA 286 (2001) 1977-1984
9. The TIMI IIIb Investigators. Effects of tissue plasminogen activator and comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Circulation 89 (1994) 1545-1556
10. Stone G.W., Grines C.L., Cox D.A., Garcia E., Tcheng J.E., Griffin J.J., Guagliumi G., Stuckey T., Turco M., Carroll J.D., et al., Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 346 (2002) 957-966
11. Lansky A., and Popma J. Qualitative and quantitative angiography. In: Topol E.J. (Ed). Textbook of Interventional Cardiology. 3rd Ed. (1999), WB Saunders, Philadelphia, PA 725-747
12. FRagmin and Fast Revascularisation during InStability in Coronary artery disease (FRISC II) Investigators. Invasive compared with non-invasive treatment in unstable coronary-artery disease. FRISC II prospective randomized multicentre study. Lancet 354 (1999) 708-715
13. The PRISM Study Investigators. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. N Engl J Med 338 (1998) 1498-1505
14. The PURSUIT Trial Investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med 339 (1998) 436-443
15. Peterson E.D., Pollack Jr. C.V., Roe M.T., Parsons L.S., Littrell K.A., Canto J.G., Barron H.V., and National Registry of Myocardial Infarction (NRMI) 4 Investigators. Early use of glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute myocardial infarction. J Am Coll Cardiol 43 (2003) 45-53
16. Stone G.W., Grines C.L., Browne K.F., Marco J., Rothbaum D., O'Keefe J., Hartzler G.O., Overlie P., Donohue B., Chelliah N., et al. Influence of acute myocardial infarction location on in-hospital and late outcome after primary percutaneous transluminal coronary angioplasty versus tissue plasminogen activator therapy. Am J Cardiol 78 (1996) 19-25
17. Garcia E., Elizaga J., Perez-Castellano N., Serrano J.A., Soriano J., Abeytua M., Botas J., Rubio R., Lopez de Sa E., Lopez-Sendon J.L., and Delcan J.L. Primary angioplasty versus systemic thrombolysis in anterior myocardial infarction. J Am Coll Cardiol 33 (1999) 605-611
18. Stone G.W., Grines C.L., Browne K.F., Marco J., Rothbaum D., O'Keefe J., Hartzler G.O., Overlie P., Donohue B., and Chelliah N. Predictors of in-hospital and 6 month outcome after acute myocardial infarction in the reperfusion era. The Primary Angioplasty in Myocardial Infarction (PAMI) Trial. J Am Coll Cardiol 25 (1995) 370-377
19. Stone G.W., Cox D., Garcia E., Brodie B.R., Morice M.C., Griffin J., Mattos L., Lansky A.J., O'Neill W.W., and Grines C.L. Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction. analysis from the primary angioplasty in myocardial infarction trials. Circulation 104 (2001) 636-641
20. Hasdai D., Granger C.B., Srivatsa S.S., Criger D.A., Ellis S.G., Califf R.M., Topol E.J., and Holmes Jr. D.R. Diabetes mellitus and outcome after primary coronary angioplasty for acute myocardial infarction. lessons from the GUSTO-IIb Angioplasty Substudy. J Am Coll Cardiol 35 (2000) 1502-1512
21. Mak K.H., and Topol E.J. Emerging concepts in the management of acute myocardial infarction in patients with diabetes mellitus. J Am Coll Cardiol 35 (2000) 563-568
22. Brodie B.R., Stuckey T.D., Wall T.C., Kissling G., Hansen C.J., Muncy D.B., Weintraub R.A., and Kelly T.A. Importance of time to reperfusion for 30 day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 32 (1998) 1312-1319
23. Berger P.B., Ellis S.G., Holmes Jr. D.R., Granger C.B., Criger D.A., Betriu A., Topol E.J., and Califf R.M. Relationship between delay and performing direct coronary angioplasty and early clinical outcomes in patients with acute myocardial infarction. results from the GUSTO-IIB trial. Circulation 100 (1999) 14-20
24. Cannon C.P., Gibson C.M., Lambrew C.T., Shoultz D.A., Levy D., French W.J., Gore J.M., Weaver W.D., Rogers W.J., and Tiefenbrunn A.J. Relationship of symptom-onset to balloon time and door to balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 283 (2000) 2841-2947
25. Holmvang L., Clemmensen P., Lindahl B., Lagerqvist B., Venge P., Wagner G., Wallentin L., and Grande P. Quantitative analysis of the admission electrocardiogram identifies patients with unstable coronary artery disease who benefit the most from early invasive treatment. J Am Coll Cardiol 41 (2003) 905-915
26. Diderholm E., Andren B., Frostfeldt G., Genberg M., Jernberg T., Lagerqvist B., Lindahl B., and Wallentin II L. ST depression in ECG at entry indicates severe coronary lesions and large benefits for an early invasive treatment strategy in unstable coronary artery disease; the FRISC II ECG substudy. The Fast Revascularisation during InStability in Coronary artery disease. Eur Heart J 23 (2002) 41-49
27. Stone G.W., and Grines C.L. Primary angioplasty in acute myocardial infarction. comparative analysis with thrombolytic therapy. In: Stack R.S., Roubin G.S., and O'Neill W.W. (Eds). Interventional Cardiovascular Medicine. Principles and Practice. 2nd Ed. (2001), Churchill Livingston, Philadelphia, PA 227-300